Delivery Order SPE2DB20D2104-SPE2DB25FMXVF
- Not listed
- The Defense Logistics Agency awarded a $1,311.62 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Otezla 30 mg on August 13, 2025, with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order represents a child contract action under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, the pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Otezla 30 mg tablets (60-count packages) with a ceiling value of $4,610.09. This firm fixed-price delivery order was awarded on August 7, 2025, with an ultimate completion date of August 8, 2025, and represents a competitive award with no set-aside designation. The order will be fulfilled from the vendor's location...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count) under a firm fixed-price contract valued at $2,623.24. The award was issued on August 1, 2025, with an ultimate completion date of August 4, 2025, and represents a non-set-aside, competitively awarded transaction. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform delivery from its corporate...
- The Defense Logistics Agency awarded a $12,258.25 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Otezla 30 mg, with an ultimate completion date of July 31, 2025. This is a firm fixed price, non-set-aside contract with performance at the vendor's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a $999,999,999.00 ceiling...
- The Defense Logistics Agency awarded a $7,869.72 delivery order to AmerisourceBergen Drug Corp for 60-count tablets of Otezla 30 mg, a pharmaceutical product for treating autoimmune conditions. This competitive award, issued on July 22, 2025, represents a firm fixed-price contract with a completion date of July 23, 2025, and carries no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,299.99 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) on August 13, 2025, with an ultimate completion date of August 14, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the contractor's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $12,445.76 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) under a firm fixed-price contract with a ceiling value of $5.25K. The award, issued on July 30, 2025, with an ultimate completion date of July 31, 2025, represents a competitively awarded, non-set-aside transaction. Performance will be conducted at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $4,576.65 to AmerisourceBergen Drug Corp for Otezla 30 mg tablets (60-count supply) on July 24, 2025, with a completion date of July 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Otezla is a prescription immunosuppressant medication used to treat various inflammatory...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) under a firm fixed-price contract valued at $43,076.07. This non-set-aside competitive award was issued on July 31, 2025, with an ultimate completion date of August 1, 2025. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMXVFDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,026.45 to AmerisourceBergen Drug Corp for 60 tablets of Otezla 30 mg on August 14, 2025, with a completion date of August 15, 2025. This firm fixed price delivery order represents a non-set-aside, competitively awarded contract and is part of a larger Indefinite Delivery Contract (IDC) vehicle—the DLA Troop Support Medical contract SPE2DX valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a prime pharmaceutical distributor supporting federal medical procurement for military and veteran healthcare systems. The delivery will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Otezla is an immunosuppressant medication used to treat conditions such as psoriasis, psoriatic arthritis, and Behçet's disease. This award reflects AmerisourceBergen's role as a critical vendor within the DLA's Medical Supply Chain, providing pharmaceutical products across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's extensive portfolio of federal contract awards demonstrates its capability to fulfill diverse pharmaceutical supply requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 8/14/25 |